Extended indication Xevinapant in combination with platinum-based chemoradiotherapy is indicated for the treatment of pa
Therapeutic value No estimate possible yet
Registration phase No registration expected

Product

Registration

Therapeutic value

Expected patient volume per year

Expected cost per patient per year

Potential total cost per year

Off label use

Indication extension

Other information